CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for YSB Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

YSB Inc
GUANGZHOU, GNG  China Ticker: 98859885
Business Summary
YSB Inc is an investment holding company mainly engaged in the provision of wholesale and retail of pharmaceuticals and healthcare products, as well as the provision of platform business services. The Company is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The Company provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The Company also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The Company principally conducts its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
7375 Information retrieval services
7372 Prepackaged software
5999 Miscellaneous retail stores, not elsewhere classified
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer BuzhenZhang 48 4/15/2022 1/1/2015
Chief Financial Officer, Executive Director, Joint Company Secretary FeiChen 39 5/14/2022 4/15/2022
Vice President HaodongXiao 59 12/1/2018 12/1/2018
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 6,306 (As of 12/31/2023)
Outstanding Shares: 640,485,502 (As of 12/31/2023)
Stock Exchange: HKG


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024